Issues related to regaining status for long acting injectables on the BOP formulary, and changes to CMS bundled payments.
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- Not reported
- Expenses
- $250,000.00
- Registrant
- INDIVIOR INC
- Client
- INDIVIOR INC
- Filing UUID
- 9dc6c945-803f-495e-8ddf-4575e1a619d5
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.